Durable remissions may be achieved with tositumomab and I131 tositumomab in recurrent and refractory B cell lymphoma.

AJ Davies; JA Radford; AZS Rohatiner; K Britton; S Owens; DP Deakin; S Howell; BM Carrington; JA Lawrence; IN Micallef; S Vinnicombe; J Clayton; J Matthews; M Harris; A Norton; TA Lister

Durable remissions may be achieved with tositumomab and I131 tositumomab in recurrent and refractory B cell lymphoma.

AJ Davies, JA Radford, AZS Rohatiner, K Britton, S Owens, DP Deakin, S Howell, BM Carrington, JA Lawrence, IN Micallef, S Vinnicombe, J Clayton, J Matthews, M Harris, A Norton, TA Lister

Research output: Contribution to journal › Meeting Abstract › peer-review

Original language	Undefined
Pages (from-to)	667
Number of pages	1
Journal	Leukemia
Volume	17
Issue number	3
Publication status	Published - Mar 2003
Event	5th International Symposium on Leukemia and Lymphoma - Vrije University, Amsterdam, Netherlands Duration: 12 Mar 2003 → 15 Mar 2003

Research Beacons, Institutes and Platforms

National Graphene Institute

Cite this

@article{96db68354cc548a9b7df70e6c7aebb76,

title = "Durable remissions may be achieved with tositumomab and I131 tositumomab in recurrent and refractory B cell lymphoma.",

author = "AJ Davies and JA Radford and AZS Rohatiner and K Britton and S Owens and DP Deakin and S Howell and BM Carrington and JA Lawrence and IN Micallef and S Vinnicombe and J Clayton and J Matthews and M Harris and A Norton and TA Lister",

year = "2003",

month = mar,

language = "Undefined",

volume = "17",

pages = "667",

journal = "Leukemia|Leukemia",

issn = "0887-6924",

publisher = "Springer Nature",

number = "3",

note = "null ; Conference date: 12-03-2003 Through 15-03-2003",

}

TY - JOUR

T1 - Durable remissions may be achieved with tositumomab and I131 tositumomab in recurrent and refractory B cell lymphoma.

AU - Davies, AJ

AU - Radford, JA

AU - Rohatiner, AZS

AU - Britton, K

AU - Owens, S

AU - Deakin, DP

AU - Howell, S

AU - Carrington, BM

AU - Lawrence, JA

AU - Micallef, IN

AU - Vinnicombe, S

AU - Clayton, J

AU - Matthews, J

AU - Harris, M

AU - Norton, A

AU - Lister, TA

PY - 2003/3

Y1 - 2003/3

UR - http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=ORCID&SrcApp=OrcidOrg&DestLinkType=FullRecord&DestApp=WOS_CPL&KeyUT=WOS:000181825300070&KeyUID=WOS:000181825300070

M3 - Meeting Abstract

VL - 17

SP - 667

JO - Leukemia|Leukemia

JF - Leukemia|Leukemia

SN - 0887-6924

IS - 3

Y2 - 12 March 2003 through 15 March 2003

ER -

Durable remissions may be achieved with tositumomab and I131 tositumomab in recurrent and refractory B cell lymphoma.

Research Beacons, Institutes and Platforms

Other files and links

Cite this